Ownership and insider activity for Drugs Made In America Acquisition II Corp. (DMIIR): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Drugs Made In America Acquisition II Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on August 23, 2024 and is headquartered in Fort Lauderdale, FL.
Price
| Price | $0.07 |
| Market Cap | $5M |
| Exchange | NASDAQ |
| Country | US |
Balance Sheet (10y)
| Year | 2024 | 2025 |
|---|---|---|
| Cash & Equivalents | $17035 | $223 |
| Short-term Investments | 0 | 0 |
| Receivables | 0 | 0 |
| Inventory | 0 | 0 |
| Total Current Assets | $59615 | $26037 |
| Property, Plant & Equipment | 0 | 0 |
| Goodwill | 0 | 0 |
| Intangible Assets | 0 | 0 |
| Total Assets | $138064 | $505.0M |
| Accounts Payable | 0 | $99359 |
| Short-term Debt | $250100 | 0 |
| Total Current Liabilities | $254782 | $300864 |
| Long-term Debt | 0 | 0 |
| Total Liabilities | $254782 | $17.8M |
| Retained Earnings | -$151719 | -$17.8M |
| Total Equity | -$116719 | $487.2M |
| Total Debt | $250100 | 0 |
| Net Debt | $233065 | -$223 |
| Working Capital | -$195167 | -$274827 |
Financial Health
| Debt / Equity | 0.00 |
| Current Ratio | 0.34 |
Profitability
| Return on Equity | 2.66% |
| Return on Invested Capital | -0.28% |
| Return on Assets | 2.53% |
| Gross Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
Explore sector: Financial Services · Financial - Conglomerates
More sections of DMIIR: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks